SOX17 and endothelial dysfunction: Mechanistic studies uncovered that SOX17 promoted transcription and release of miR‐224‐5p and miR‐361‐3p, thereby targeting NR4A3 and PCSK9 to improve endothelial dysfunction (Figure7).